NCT06927843View on ClinicalTrials.gov

Investigational Study to Evaluate the DPP® Syphilis Screen & Confirm Antibody Point-of-care Test (POCT) to Diagnose Infectious Syphilis

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

March 5, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions
Syphilis
Interventions
DEVICE

point of care test

DPP Syphilis Screen and Confirm antibody point-of-care-test (POCT)

Trial Locations (1)

R3G 0X2

RECRUITING

Nine Circles Community Health Centre, Winnipeg

Sponsors
All Listed Sponsors
collaborator

Public Health Agency of Canada (PHAC)

OTHER_GOV

collaborator

Chembio Diagnostic Systems, Inc.

INDUSTRY

lead

University of Manitoba

OTHER

NCT06927843 - Investigational Study to Evaluate the DPP® Syphilis Screen & Confirm Antibody Point-of-care Test (POCT) to Diagnose Infectious Syphilis | Biotech Hunter | Biotech Hunter